Abstract
Radiometals have become increasingly important because of their use both for diagnostic molecular imaging and therapy in Nuclear Medicine. The focus is on the study of biochemical processes at cellular and sub-cellular level in order to detect metabolic abnormalities associated with various diseases. For that purpose, molecules that selectively accumulate in the organ or tissue of interest by a specific mechanism such as receptor binding or interaction with biomolecules are labeled with 99mTc, 68Ga, 153Sm, 186/188Re, 177Lu, among others and used as radiopharmaceuticals. However, considerable effort is necessary to combine these radionuclides with biomolecules relevant to different pathological conditions. Intensive research on the coordination chemistry of these metals has led to novel labeling methods that yield stable compounds which retained the original biological activity of the ligand. Chemical aspects and clinical applications will be reviewed in this paper.
Keywords: Nuclear medicine, radiopharmaceuticals, metals, radionuclides, diagnosis, radiotherapy, Radiometal Complexes, Molecular Imaging, Therapeutic Nuclear Medicine, TECHNETIUM, Tc generator system, Tc-DTPA complex, technetium complexes, osteogenic activity, glucoheptonate, tartrate, Tc-ECD complex, Tc-MIBI, Tc-sestamibi, Tc-sestamibi complex, Tc-TRODAT-1, Technetium-HYNIC complex, Click Chemistry, somatostatine receptors, neurotensin, cholecystokinin-B/gastrin, RHENIUM, Rhenium compounds, Re, –, biphosphonates, (188Re-SOCTA-trastuzumab, poliaza macrocycles, DOTA-RGD, Ga-DOTA, (EC-MN), Zr-labeled Antibody
Current Medicinal Chemistry
Title: Radiometal Complexes in Molecular Imaging and Therapy
Volume: 17 Issue: 31
Author(s): A. M. Rey
Affiliation:
Keywords: Nuclear medicine, radiopharmaceuticals, metals, radionuclides, diagnosis, radiotherapy, Radiometal Complexes, Molecular Imaging, Therapeutic Nuclear Medicine, TECHNETIUM, Tc generator system, Tc-DTPA complex, technetium complexes, osteogenic activity, glucoheptonate, tartrate, Tc-ECD complex, Tc-MIBI, Tc-sestamibi, Tc-sestamibi complex, Tc-TRODAT-1, Technetium-HYNIC complex, Click Chemistry, somatostatine receptors, neurotensin, cholecystokinin-B/gastrin, RHENIUM, Rhenium compounds, Re, –, biphosphonates, (188Re-SOCTA-trastuzumab, poliaza macrocycles, DOTA-RGD, Ga-DOTA, (EC-MN), Zr-labeled Antibody
Abstract: Radiometals have become increasingly important because of their use both for diagnostic molecular imaging and therapy in Nuclear Medicine. The focus is on the study of biochemical processes at cellular and sub-cellular level in order to detect metabolic abnormalities associated with various diseases. For that purpose, molecules that selectively accumulate in the organ or tissue of interest by a specific mechanism such as receptor binding or interaction with biomolecules are labeled with 99mTc, 68Ga, 153Sm, 186/188Re, 177Lu, among others and used as radiopharmaceuticals. However, considerable effort is necessary to combine these radionuclides with biomolecules relevant to different pathological conditions. Intensive research on the coordination chemistry of these metals has led to novel labeling methods that yield stable compounds which retained the original biological activity of the ligand. Chemical aspects and clinical applications will be reviewed in this paper.
Export Options
About this article
Cite this article as:
M. Rey A., Radiometal Complexes in Molecular Imaging and Therapy, Current Medicinal Chemistry 2010; 17 (31) . https://dx.doi.org/10.2174/092986710793213733
DOI https://dx.doi.org/10.2174/092986710793213733 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) The Importance of Integrating SNP and Cheminformatics Resources to Pharmacogenomics
Current Drug Metabolism Regulatory T Cells in Cancer Biology: A Possible New Target for Biochemical Therapies
Mini-Reviews in Medicinal Chemistry Can't Always Get What you Want? Try an Indirect Route you Just Might Get What you Need: A Study on Access to Genetic Data by Canadian Life Insurers
Current Pharmacogenomics and Personalized Medicine Transcatheter Aortic Valve Implantation Infective Endocarditis: Current Data and Implications on Prophylaxis and Management
Current Pharmaceutical Design FAT10: Function and Relationship with Cancer
Current Molecular Pharmacology Efficacy and Safety of Bevacizumab in Glioblastomas
Current Medicinal Chemistry Inflammatory Mediators in Epilepsy
Current Pharmaceutical Design Brain Inflammation Following Intracerebral Hemorrhage
Current Neuropharmacology A Role for Milk Proteins and their Peptides in Cancer Prevention
Current Pharmaceutical Design Counselling and Cognitive Behaviour Interventions Delivered to Reduce Psychological Morbidity and Improve Quality of Life in Gynaecological Cancer Patients: Recent Achievements
Current Women`s Health Reviews Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies
Current Pharmaceutical Design A Validated Stability-Indicating HPTLC Method for the Estimation of Capecitabine in its Tablet Dosage Form
Current Pharmaceutical Analysis Xenobiotic Sulphation and its Variability During Inflammation: a Factor in Adverse Drug Reactions?
Current Drug Metabolism Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology The Role of Microbiota and Intestinal Permeability in the Pathophysiology of Autoimmune and Neuroimmune Processes with an Emphasis on Inflammatory Bowel Disease Type 1 Diabetes and Chronic Fatigue Syndrome
Current Pharmaceutical Design Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer
Current Cancer Drug Targets Understanding the Use of Immunosuppressive Agents in the Clinical Management of IBD
Current Drug Targets Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Current Protein & Peptide Science